Feasibility study on the use of gold nanoparticles in fractionated kilovoltage X-ray treatment of melanoma

References

• Alpen EL. 1998. Theories and models for cell survival: survival curve and its significance radiation biophysics. 2nd ed. San Diego, California: Academic Press; p. 111–162.
   Google Scholar
• Bae YH, Park K. 2011. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 153:198–205.
   PubMed Web of Science ®Google Scholar
• Banath JP, Olive PL. 2003. Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks. Cancer Res. 63:4347–4350.
   PubMed Web of Science ®Google Scholar
• Barkey NM, Tafreshi NK, Josan JS, De Silva CR, Sill KN, Hruby VJ, Gillies RJ, Morse DL, Vagner J. 2011. Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand. J Med Chem. 54:8078–8084.
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L, Blanchette JO. 2004. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 56:1649–1659.
   PubMed Web of Science ®Google Scholar
• Brigger I, Dubernet C, Couvreur P. 2002. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 54:631–651.
   PubMed Web of Science ®Google Scholar
• Carter JD, Cheng NN, Qu Y, Suarez GD, Guo T. 2007. Nanoscale energy deposition by X-ray absorbing nanostructures. J Phys Chem B. 111:11622–11625.
   PubMed Web of Science ®Google Scholar
• Chen KG, Gottesman MM. 2005. How melanoma cells evade chemotherapy: role of transporter-dependent and -independent resistance mechanisms. In: Hearing VJ, Leong SPL, editors. From melanocytes to melanoma: the progression to malignancy. Totowa: Humana Press Inc; p. 591–603.
   Google Scholar
• Chen KG, Leapman RD, Zhang G, Lai B, Valencia JC, Cardarelli CO, Vieira WD, Hearing VJ, Gottesman MM. 2009. Influence of melanosome dynamics on melanoma drug sensitivity. J Natl Cancer Inst. 101:1259–1271.
   PubMedGoogle Scholar
• Chithrani DB. 2010. Intracellular uptake, transport, and processing of gold nanostructures. Mol Membr Biol. 27:299–311.
   PubMed Web of Science ®Google Scholar
• Dale R. 2004. Use of the linear-quadratic radiobiological model for quantifying kidney response in targeted radiotherapy. Cancer Biother Radiopharm. 19:363–370.
   PubMed Web of Science ®Google Scholar
• Dunne AL, Mothersill C, Robson T, Wilson GD, Hirst DG. 2004. Radiosensitization of colon cancer cell lines by docetaxel: mechanisms of action. Oncol Res. 14:447–454.
   PubMed Web of Science ®Google Scholar
• Gao H, Yang Z, Zhang S, Cao S, Shen S, Pang Z, Jiang X. 2013. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci Rep. 3:2534.
   PubMed Web of Science ®Google Scholar
• Gaumet M, Vargas A, Gurny R, Delie F. 2008. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm. 69:1–9.
   PubMed Web of Science ®Google Scholar
• Ghosh P, Han G, De M, Kim CK, Rotello VM. 2008. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 60:1307–1315.
   PubMed Web of Science ®Google Scholar
• Hall EJ, Giaccia AJ. 2012. Cell survival curves: radiobiology for the radiologist. 7th ed. Philadelphia: Lippincott Williams & Wilkins; p. 37–40.
   Google Scholar
• Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. 1998. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci. 95:4607–4612.
   PubMed Web of Science ®Google Scholar
• Jain S, Coulter JA, Hounsell AR, Butterworth KT, McMahon SJ, Hyland WB, Muir MF, Dickson GR, Prise KM, Currell FJ, et al. 2011. Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int J Radiat Oncol Biol Phys. 79:531–539.
   PubMed Web of Science ®Google Scholar
• Jones G, Brooks PM. 1996. Injectable gold compounds: an overview. Br J Rheumatol. 35:1154–1158.
   PubMedGoogle Scholar
• Khlebtsov N, Dykman L. 2011. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev. 40:1647–1671.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Tannock IF. 2005. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer. 5:516–525.
   PubMed Web of Science ®Google Scholar
• Kim SR, Kim EH. 2017. Gold nanoparticles as dose-enhancement agent for kilovoltage X-ray therapy of melanoma. Int J Radiat Biol. 93:517–526.
   PubMed Web of Science ®Google Scholar
• Lechtman E, Chattopadhyay N, Cai Z, Mashouf S, Reilly R, Pignol JP. 2011. Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location. Phys Med Biol. 56:4631–4647.
   PubMed Web of Science ®Google Scholar
• Lee KM, Kim SR, Kim EH. 2012. Characterization of dose delivery in a hard X-ray irradiation facility. J Nucl Sci Technol. 49:655–661.
   Web of Science ®Google Scholar
• Li SD, Huang L. 2008. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm. 5:496–504.
   PubMed Web of Science ®Google Scholar
• Lu W, Xiong C, Zhang G, Huang Q, Zhang R, Zhang JZ, Li C. 2009. Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin Cancer Res. 15:876–886.
   PubMed Web of Science ®Google Scholar
• McDonald DM, Baluk P. 2002. Significance of blood vessel leakiness in cancer. Cancer Res. 62:5381–5385.
   PubMed Web of Science ®Google Scholar
• McGregor S, Minni J, Herold D. 2015. Superficial radiation therapy for the treatment of nonmelanoma skin cancers. J Clin Aesthet Dermatol. 8:12–14.
   PubMedGoogle Scholar
• McMahon SJ, Hyland WB, Muir MF, Coulter JA, Jain S, Butterworth KT, Schettino G, Dickson GR, Hounsell AR, O’Sullivan JM, et al. 2013. Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles. Sci Rep. 3:1725.
   Web of Science ®Google Scholar
• Mickler FM, Mockl L, Ruthardt N, Ogris M, Wagner E, Brauchle C. 2012. Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand. Nano Lett. 12:3417–3423.
   PubMed Web of Science ®Google Scholar
• Pradhan AK, Nahar SN, Montenegro M, Yu Y, Zhang HL, Sur C, Mrozik M, Pitzer RM. 2009. Resonant X-ray enhancement of the Auger effect in high-Z atoms, molecules, and nanoparticles: potential biomedical applications. J Phys Chem A. 113:12356–12363.
   PubMed Web of Science ®Google Scholar
• Prise KM, Schettino G, Folkard M, Held KD. 2005. New insights on cell death from radiation exposure. Lancet Oncol. 6:520–528.
   PubMed Web of Science ®Google Scholar
• Roa W, Zhang X, Guo L, Shaw A, Hu X, Xiong Y, Gulavita S, Patel S, Sun X, Chen J, et al. 2009. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology. 20:375101.
   PubMed Web of Science ®Google Scholar
• Rosenkranz AA, Slastnikova TA, Durymanov MO, Sobolev AS. 2013. Malignant melanoma and melanocortin 1 receptor. Biochemistry (Mosc). 78:1228–1237.
   PubMed Web of Science ®Google Scholar
• Sarin H. 2010. Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability. J Angiogenes Res. 2:14.
   PubMedGoogle Scholar
• Sinesi C, McNeese MD, Peters LJ, Goepfert H, Kong J, Mills MD. 1987. Electron beam therapy for eyelid carcinomas. Head Neck Surg. 10:31–37.
   PubMedGoogle Scholar
• Song CW, Park HJ, Griffin RJ, Levitt SH. 2012. Radiobiology of stereotactic radiosurgery and stereotactic body radiation therapy. In: Levitt SH, Purdy JA, Perez CA, Poortmans P, editors. Technical basis of radiation therapy: practical clinical applications. 5th ed. Berlin Heidelberg: Springer; p. 51–62.
   Google Scholar